Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review
It is over 50 years since the discovery of microtubules, and they have become one of the most important drug targets for anti-cancer therapies. Microtubules are predominantly composed of the protein tubulin, which contains a number of different binding sites for small-molecule drugs. There is contin...
Saved in:
Main Authors: | Eavan C. McLoughlin (Author), Niamh M. O'Boyle (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: McLoughlin, E.C.; O'Boyle, N.M. Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review. <i>Pharmaceuticals</i> 2020, <i>13</i>, 8
by: Eavan C. McLoughlin, et al.
Published: (2020) -
Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors
by: Yongfang Yao, et al.
Published: (2022) -
Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors
by: Moran Sun, et al.
Published: (2022) -
Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation
by: Wei Liu, et al.
Published: (2023) -
Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation
by: Mohamed Hagras, et al.
Published: (2021)